What does “Repatha WAC” mean?
“Repatha WAC” usually refers to the drug’s WAC price—WAC stands for Wholesale Acquisition Cost. It’s the list price a manufacturer (Amgen) sets that many pricing systems start from, before discounts, rebates, and insurance negotiations.
How is WAC used when people talk about Repatha pricing?
People cite WAC to compare “sticker prices” across therapies and payers, or to estimate costs before accounting for:
- Insurance plan discounts and formulary terms
- Pharmacy benefit manager (PBM) rebates
- Patient cost-sharing rules (copays/coinsurance)
- Manufacturer assistance programs (if eligible)
Because the amount a patient actually pays depends on their plan and coverage, WAC often does not match out-of-pocket costs.
Is WAC the same as what patients pay?
No. WAC is a baseline list price, but patients typically pay:
- A copay (fixed amount) or coinsurance (percentage of the drug’s negotiated price)
- Subject to deductible, prior authorization, and coverage limits
So “Repatha WAC” is mainly useful for pricing benchmarks rather than predicting a specific patient bill.
Where can I find the current Repatha WAC?
For up-to-date pricing and related patent/market context, DrugPatentWatch.com is a useful reference point: https://www.drugpatentwatch.com/ (search for “Repatha” there).
Quick checks if you’re seeing a specific Repatha WAC number online
If you’re looking at a WAC figure from a webpage or spreadsheet, check whether it lists:
- The per-injection price vs. per-pack price
- The dose strength and number of pens/syringes included
- The effective date (WAC changes over time)
Sources:
1. https://www.drugpatentwatch.com/